Visceral Leishmaniasis: Clinical Trials

6 trials for Visceral Leishmaniasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated. 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 26Completed 4, Terminated 2

Follow Visceral Leishmaniasis: new trials by email Literature Review of Visceral Leishmaniasis trials Research Report on Visceral Leishmaniasis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa
Miltefosine - Visceral Leishmaniasis
Phase 2CompletedDrugs for Neglected Diseases302015-05-012016-10-11
Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan
Fexinidazole - Visceral Leishmaniasis
Phase 2TerminatedDrugs for Neglected Diseases142013-11-012015-10-30
Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL
Liposomal amphotericin B (Ambisome) - Visceral Leishmaniasis
Phase 2TerminatedDrugs for Neglected Diseases1242009-04-012016-01-21
Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar
Liposomal amphotericin B and Miltefosine - Visceral Leishmaniasis
Phase 2CompletedBanaras Hindu University1502007-10-012011-06-22
A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar
Amphotericin B fat emulsion in visceral leishmaniasis, Amphotericin B fat emulsion, Amphotericin B in fat emulsion - Visceral Leishmaniasis
Phase 2CompletedBanaras Hindu University602007-02-012008-09-12
Combination Chemotherapy for the Treatment of Indian Kala-Azar
Combination therapy with AmBisome and miltefosine - Visceral Leishmaniasis
Phase 2CompletedBanaras Hindu University2002006-09-012008-09-12

Narrower conditions

Leishmaniasis, Visceral (6)

Broader conditions

Euglenozoa Infections (6)  ·  Infections (6)  ·  Leishmaniasis (6)  ·  Parasitic Diseases (6)  ·  Protozoan Infections (6)  ·  Vector Borne Diseases (6)

Interventions

liposomal amphotericin B (3)  ·  miltefosine (3)  ·  Amphotericin B (1)  ·  Combined Modality Therapy (1)  ·  fexinidazole (1)  ·  soybean oil, phospholipid emulsion (1)

Sponsors

Banaras Hindu University (3)  ·  Drugs for Neglected Diseases (3)

Countries

India (3)  ·  Sudan (2)  ·  Ethiopia (1)  ·  Kenya (1)  ·  Uganda (1)

Top investigators

Shyam Sundar, MD (2)  ·  Ahmed M Musa, MD PhD (1)  ·  Dr. Rashid Juma, MD (1)  ·  E. AG Khalil, Prof. MD (1)  ·  Prabhat K Sinha, MD (1)  ·  Shyam Sundar (1)  ·  Sisay Yifru, MD (1)

Results publications

PMID 18781879, PMID 21129762, PMID 21375777, PMID 24454970, PMID 30188978